ÂÜÀòÂÒÂ×

Phyllis Feeney serves as a Corporate Board Member at Diverse Biotech since February 2020, contributing to the innovation in biopharmaceutical research focused on cancer therapeutics. Prior to this role, Phyllis Feeney held several key positions at Bristol-Myers Squibb from July 1995 to December 2019, including Executive Director of Pricing & Reimbursement, where strategic oversight of pricing and contract operations was provided. As Vice-President Finance for the U.S. CV/Metabolics division, Phyllis Feeney managed financial operations for a high-growth franchise. Other notable positions include VP and Assistant Controller for Corporate Financial Analysis, offering analytical support to top executives, and Senior Director of Financial Analysis for Mergers & Acquisitions, specializing in economic evaluations for business development opportunities. Phyllis Feeney holds a Sc.B. in Biology from Brown University and an MBA in Finance from The Wharton School.